Patents by Inventor Frank B. Myers, III

Frank B. Myers, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11954851
    Abstract: A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: April 9, 2024
    Assignee: Pfizer Inc.
    Inventors: Ivan Krastev Dimov, Frank B. Myers, III, John Robert Waldeisen, Debkishore Mitra
  • Publication number: 20240020836
    Abstract: A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.
    Type: Application
    Filed: August 2, 2023
    Publication date: January 18, 2024
    Inventors: Ivan Krastev Dimov, Frank B. Myers, III, John Robert Waldeisen, Debkishore Mitra
  • Publication number: 20230311130
    Abstract: The present disclosure provides assay and method for using assay for streamlined assay preparation and testing. These assay are useful for pathogen (e.g., viral or bacterial) detection. The present disclosure also provides assay assemblies and means to prevent or minimize the formation of bubbles when using puncturing elements in fluidic devices or chambers.
    Type: Application
    Filed: September 4, 2021
    Publication date: October 5, 2023
    Inventors: Clay Reber, Kelly Lewis Brezoczky, Thomas Brezoczky, Frank B. Myers, III, Debkishore Mitra, Tark Abed, Alexander N. Dzigurski, Bron Davis
  • Patent number: 11465142
    Abstract: This invention relates generally to devices, systems, and methods for performing biological assays by using indicators that modify one or more optical properties of the assayed biological samples. The subject methods include generating a reaction product by carrying out a biochemical reaction on the biological sample introduced into a device and reacting the reaction product with an indicator capable of generating a detectable change in an optical property of the biological sample to indicate the presence, absence, or amount of analyte suspected to be present in the sample.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: October 11, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Frank B. Myers, III, Clay D. Reber, Taber H. Smith, Faisal S. Maniar
  • Publication number: 20220280939
    Abstract: Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include a selective venting element having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.
    Type: Application
    Filed: February 22, 2022
    Publication date: September 8, 2022
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20220134327
    Abstract: This invention relates generally to devices, systems, and methods for avoiding bubble formation in a fluidic chamber during filling of the fluidic chamber with a liquid. A first and second piece are operatively coupled to form the fluidic chamber. A protrusion protrudes into a volume of the fluidic chamber such that there is a distance of minimal approach between an apex of the protrusion and a surface of the fluidic chamber. The protrusion forms a channel that extends from one of an inlet and the outlet of the fluidic chamber to the protrusion apex. A maximum distance of travel through the fluidic chamber volume exists between the inlet and the outlet. A cross-sectional area of the fluidic chamber volume increases from the protrusion apex to a transverse plane of the fluidic chamber and decreases from the transverse plane to the other one of the inlet and the outlet.
    Type: Application
    Filed: March 3, 2020
    Publication date: May 5, 2022
    Inventors: Frank B. Myers, III, Clay D. Reber, Taber H. Smith, Faisal S. Maniar
  • Publication number: 20220108439
    Abstract: A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.
    Type: Application
    Filed: June 30, 2021
    Publication date: April 7, 2022
    Inventors: Ivan Krastev Dimov, Frank B. Myers, III, John Robert Waldeisen, Debkishore Mitra
  • Patent number: 11291995
    Abstract: Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include (a) a sample receiving cartridge comprising a sample inlet and one or more reaction chambers and (b) a selective venting element having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: April 5, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20220055030
    Abstract: Systems and methods for performing biological assays are provided herein. The systems and methods determine one or more characteristics of a nucleic acid amplification sample based on a modified optical property of the sample.
    Type: Application
    Filed: June 8, 2021
    Publication date: February 24, 2022
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20220057305
    Abstract: Devices and methods for preparing and delivering biological assay samples are provided herein. Components of such devices include a sample receiving module within which a biological assay sample can be prepared and a cap, which when operatively coupled with the sample receiving module, pressurizes the module. These devices can be employed for subsequently delivering a biological assay sample.
    Type: Application
    Filed: August 3, 2021
    Publication date: February 24, 2022
    Inventors: Frank B. Myers, III, Wei Hsuan Ho, Debkishore Mitra, John Robert Waldeisen, Ivan Krastev Dimov, Ryan C. Griswold, Bruce Richardson
  • Patent number: 11125661
    Abstract: Devices and methods for preparing and delivering biological assay samples are provided herein. Components of such devices include a sample receiving module within which a biological assay sample can be prepared and a cap, which when operatively coupled with the sample receiving module, pressurizes the module. These devices can be employed for subsequently delivering a biological assay sample.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: September 21, 2021
    Assignee: Lucira Health. Inc.
    Inventors: Frank B. Myers, III, Wei Hsuan Ho, Debkishore Mitra, John Robert Waldeisen, Ivan Krastev Dimov, Ryan C. Griswold, Bruce Richardson
  • Patent number: 11123736
    Abstract: Systems and methods for performing biological assays are provided herein. The systems and methods determine one or more characteristics of a nucleic acid amplification sample based on a modified optical property of the sample.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: September 21, 2021
    Assignee: Lucira Health, Inc.
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Patent number: 11080848
    Abstract: A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: August 3, 2021
    Assignee: Lucira Health, Inc.
    Inventors: Ivan Krastev Dimov, Frank B. Myers, III, John Robert Waldeisen, Debkishore Mitra
  • Publication number: 20200122142
    Abstract: This invention relates generally to devices, systems, and methods for performing biological assays by using indicators that modify one or more optical properties of the assayed biological samples. The subject methods include generating a reaction product by carrying out a biochemical reaction on the biological sample introduced into a device and reacting the reaction product with an indicator capable of generating a detectable change in an optical property of the biological sample to indicate the presence, absence, or amount of analyte suspected to be present in the sample.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Inventors: Frank B. Myers, III, Clay D. Reber, Taber H. Smith, Faisal S. Maniar
  • Patent number: 10578851
    Abstract: An automated slide scanning system, comprising one or more optical elements, including an objective, having an optical path configured to be disposed within view of a camera of a portable device. An automated stage disposed within the optical path, the automated stage comprising a platform configured for receiving a slide containing a biological sample and having a drive mechanism for translating the stage in at least one direction with respect to said objective. A communications interface coupled to the automated stage, and is configured for receiving a command from the portable device to control operation of the mechanical stage.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: March 3, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Daniel A. Fletcher, Michael V. D'Ambrosio, Arunan Skandarajah, Frank B. Myers, III, Clay D. Reber
  • Patent number: 10549275
    Abstract: This invention relates generally to devices, systems, and methods for performing biological assays by using indicators that modify one or more optical properties of the assayed biological samples. The subject methods include generating a reaction product by carrying out a biochemical reaction on the biological sample introduced into a device and reacting the reaction product with an indicator capable of generating a detectable change in an optical property of the biological sample to indicate the presence, absence, or amount of analyte suspected to be present in the sample.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: February 4, 2020
    Assignee: Lucira Health, Inc.
    Inventors: Frank B. Myers, III, Clay D. Reber, Taber H. Smith, Faisal S. Maniar
  • Publication number: 20200030798
    Abstract: Selectively vented biological assay devices and methods of performing biological assays with such devices are provided herein. Disclosed devices include a selective venting element having passively tunable porosity. The methods include controlling fluid flow within the subject devices with the selective venting element.
    Type: Application
    Filed: March 14, 2017
    Publication date: January 30, 2020
    Inventors: Debkishore Mitra, Frank B. Myers, III, John Robert Waldeisen, Ivan Krastev Dimov
  • Publication number: 20190094114
    Abstract: Devices and methods for preparing and delivering biological assay samples are provided herein. Components of such devices include a sample receiving module within which a biological assay sample can be prepared and a cap, which when operatively coupled with the sample receiving module, pressurizes the module. These devices can be employed for subsequently delivering a biological assay sample.
    Type: Application
    Filed: March 14, 2017
    Publication date: March 28, 2019
    Inventors: Frank B. Myers, III, Wei Hsuan Ho, Debkishore Mitra, John Robert Waldeisen, Ivan Krastev Dimov, Ryan C. Griswold, Bruce Richardson
  • Patent number: D953561
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: May 31, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Clay Reber, Kelly Lewis Brezoczky, Thomas Brezoczky, Frank B. Myers, III, Debkishore Mitra
  • Patent number: D962470
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: August 30, 2022
    Assignee: Lucira Health, Inc.
    Inventors: Clay Reber, Kelly Lewis Brezoczky, Thomas Brezoczky, Frank B. Myers, III, Debkishore Mitra